18 -19
November

Venture Capital & Private Equity Boston

Investment Challenges and Opportunities in Emerging Biotech Markets

Le Meridien Cambridge Boston

What to expect

Timely information, interactive format

Real insights are shared in conversations, not lectures. That’s why our unique roundtable format guarantees real learning and ensures you only attend discussions that deliver value to you.

Join as many as four roundtable discussions, each with up to 20 other subject experts, networking with top-level peers in an informal, relaxed and sociable environment.

Meet Our Facilitators

Our panel of facilitators plays a key role in shaping the agenda for the day. Whilst we’re busy connecting with the best industry experts, take a look at our facilitators.

Andrew Meadow

Partner; Chief Investment Officer Health Innovation Capital

David Sherris

CEO Attivare Therapeutics

Session – Next Generation OV and New Combinational Approaches for Treatment of Solid Tumors 
Dr. Sherris has over 30 years’ experience in translational medicine involving basic research, pharmaceutics and diagnostics.  Dr. Sherris has been a successful serial entrepreneur developing biotechnology companies from the ground up, devising corporate strategy, enacting programs and carrying companies through funding and acquisition.  Dr. Sherris prides himself as a “roll up your sleeves” CEO, entrepreneur, business development officer, drug developer and scientist, not simply a delegator. Dr. Sherris has worked with venture capital companies where he has both advised and raised finances for biotech companies.  Dr. Sherris has been employed by pharmaceutical and biotechnology companies to manage external (academic groups and contract research organizations) and internal (directly manage, augment and expand internal scientific programs) research and development. Dr. Sherris has been a frequently invited guest speaker at biopharmaceutical business and scientific conferences, a published author and holder of patents in a wide range of therapeutic areas including oncology, ophthalmology, dermatology, neurology, gene therapy and infectious disease.  Dr. Sherris has held positions of increasing responsibility in public and private companies. Dr. Sherris has developed drugs from the bench to the clinic, partnered technologies to pharmaceutical companies and raised capital for companies at the triple digit million dollar levels.

Christina Ansted

Senior Managing Partner RCP Venture Capital

Robert Gabriel

Board Member, Managing Partner Ashur Capital

Our Agenda

Private Equity, Venture Capital & Strategic Partnerships
Maximizing ROI in Clinical Trials: Navigating Risk, Innovation, and Opportunity

Private Equity, Venture Capital & Strategic Partnerships
Balancing Cost-Effectiveness with Data Reliability in Decentralized Models

Private Equity, Venture Capital & Strategic Partnership
Exploring the Key Strategies for Improving the Cost-Efficiency of Clinical Trials and Increasing ROI for Investors?

Robert Gabriel,
Board Member, Managing Partner,
Ashur Capital

Private Equity, Venture Capital & Strategic Partnerships
Evaluating the Role of Strategic Partnerships in Mitigating Risks and Enhancing Funding or Expertise for Clinical Trials

Private Equity, Venture Capital & Strategic Partnerships
De-Risking Investment in Clinical Trials: Strategies for Startups and VCs

Private Equity, Venture Capital & Strategic Partnerships
What Are the Emerging Trends in Venture Capital for Drug Discovery and Biotech Startups?

Private Equity, Venture Capital & Strategic Partnerships
Early-Stage Science, Late-Stage Discipline: What Today’s Investors Want

Private Equity, Venture Capital & Strategic Partnerships
Strategic Alliances and Investment Strategies: Fueling the Future of Drug Discovery

Private Equity, Venture Capital & Strategic Partnerships
Partnering for Progress: How Big Pharma & Biotech Forge the Next Wave of Innovation

Private Equity, Venture Capital & Strategic Partnerships
Topic TBC

David Sherris,
President and CEO,
Attivare Therapeutics

Engage in Real Conversations That Matter

Our unique roundtable format fosters meaningful dialogue—not lectures—so you gain actionable insights from every discussion. Choose up to four roundtable sessions, each limited to 20 participants, and connect with senior-level peers in a relaxed, collaborative setting.

Choose Your Venture Date

*First name

*Last name

*Company name

*Job Title

*First line of address

*City

*Postcode/Zipcode

*Country

*Work Email

*Direct Line

*Mobile/Cell

*What are your 3 main strategic challenges?

Do you have dietary requirements?

YesNo

If yes please indicate

***We Highly Recommend to Use Google Chrome, Safari or Firefox Browser.

I hereby consent Proventa International to collect and share my provided contact details to other delegates and sponsors attending the same event I am attending.

I agree to Proventa International using this information to contact me about relevant content, products, and services. You may unsubscribe at any time. For more information, check out our Privacy Policy.

Further Information

Interested in attending this virtual roundtable or running your own? Drop us a message today and we will get in touch

Here To Help

Need help registering your team? Just get in touch and a member of the team will be happy to help.

Europe

USA East

USA West

Webinars

Europe

R&D

Investment Dinners & Spotlights

Venture Capital & Private Equity

Venture Capital & Private Equity Boston

<img class="lazy" decoding="async" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%2012%2016'%3E%3C/svg%3E" data-src="https://proventainternational.com/wp-content/uploads/2020/12/location.png" >Le Meridien Cambridge Boston

Timely information, interactive format

Meet Our Facilitators

Andrew Meadow

David Sherris

Christina Ansted

Robert Gabriel

Our Agenda

Day 1 : 18th of Nov, 2025

Registration And Welcome

Opening Keynote Presentation

Roundtable Roundtable Tracks

Refreshment Break

Networking / 1-1 Meetings

Roundtable Roundtable Tracks

Roundtable Roundtable Tracks

Networking Lunch

Networking / 1-1 Meetings

Networking / 1-1 Meetings

Afternoon Keynote Presentation

Roundtable Roundtable Tracks

Afternoon Refreshment Break

PANEL DISCUSSION

Drinks & Canapes Reception

Day 2 : 19th of November, 2025

Registration And Welcome

Opening Keynote Presentation

Roundtable

Refreshment Break

Networking / 1-1 Meetings

Roundtable Roundtable Tracks

Roundtable Roundtable Tracks

Networking Lunch

Networking / 1-1 Meetings

Networking / 1-1 Meetings

Afternoon Keynote Presentation

Roundtable Roundtable Tracks

Afternoon Refreshment Break

PANEL DISCUSSION

Drinks & Canapes Reception

Engage in Real Conversations That Matter

You had been successfully registered.

Further Information

Here To Help

Select days you wish to attend You can add multiple days

VAT Excluded

Select days you wish to attend You can add multiple days

Pass includes:

VAT Excluded

About You

Your Address

About Your Company

This is required field*

Bone/Osteoporosis

Immunology

Orthopaedics

Cardiovascular

Infectious diseases

Pulmonology

CNS

Inflammation

Psychiatry

Dermatology

Internal diseases

Respiratory

Diabetes

Metabolic diseases

Rheumatology

Endocrinology

Nephrology

Surgery

Le Meridien Cambridge Boston